• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals


56.2100 USD 4.3100 8.30%

As of 20:04:06 ET on 07/30/2014.

Snapshot for Hospira Inc (HSP)

Open: 52.7800 Day's Range: 52.7800 - 56.4800 Volume: 3,768,368
Previous Close: 51.9000 52wk Range: 38.1100 - 56.4800 1-Yr Rtn: +38.11%

Stock Chart for HSP

No chart data available.
  • HSP:US 56.2100
  • 1D
  • 1M
  • 1Y
Interactive HSP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HSP

Current P/E Ratio (ttm) 30.6039
Estimated P/E(12/2014) 24.3544
Relative P/E vs. SPX 1.7025
Earnings Per Share (USD) (ttm) 1.8367
Est. EPS (USD) (12/2014) 2.3080
Est. PEG Ratio 1.9899
Market Cap (M USD) 9,484.41
Shares Outstanding (M) 168.73
30 Day Average Volume 1,118,193
Price/Book (mrq) 2.9137
Price/Sale (ttm) 2.1867
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HSP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HSP

Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.

F Michael Ball "Mike"Chief Executive OfficerDavid John EndicottPres:Medical Devices
Daphne E JonesSenior VP/CIOBrian J SmithSenior VP/Chief Legal Officer
More Company Profile & Key Executives for HSP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil